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Human Research Protection Of ice

New Member
Training
Guidance for the Non‐
Scientist IRB Member
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Welcome!
Thank you for joining the Washington University in St. Louis Ins tu onal Review Board (IRB). We greatly
appreciate your contribu on and hope to make your experience engaging and rewarding. In general, IRB
members volunteer their me and exper se because of their interest in the kinds of research conducted at WU
and their concern for the rights, safety, and welfare of volunteers and/or pa ents who par cipate in research. In
becoming a member of the WU IRB, you contribute in a very real way to both the progress of new scien fic
knowledge, the well‐being of research par cipants, and the vitality of the St. Louis community.

What Does an IRB Do?

Mission Statement

Medical research on human subjects has
long been prac ced by doctors and
researchers, however, this research has not
always been conducted in an ethical
manner. IRBs are mandated by the federal
government to protect the rights and
welfare of research par cipants at a given
ins tu on, and are founded on the three
principles of ethical research established in
the Belmont Report (1979): jus ce,
beneficence, and respect for persons.

As a member of the Washington
University in St. Louis IRB, your mandate is
to par cipate in the review of research to
ensure that approved protocols meet
ethical, regulatory, and ins tu onal
requirements, and to protect the rights
and welfare of human research
par cipants in “human research” as
defined in 45 CFR 46.102(d) and (f) and
“clinical inves ga ons” as defined in 21
CFR 50.3(c).
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IRB Membership


Chair
The Commi ee Chair guides discussion,
vo ng, and regulatory decision‐making.



Scien st
Members whose primary concerns are in
scien fic areas provide the exper se necessary
to evaluate specific types of research. These IRB
members are able to contribute things like risks
and benefit evalua on, assessments of
par cipant vulnerabili es, and confirma on of
consent form accuracy. (The WU IRB
dis nguishes between “Physician
Scien sts” and “Other Scien sts.”)



The regula ons (45 CFR 46.107/21
CFR 56.107) describe specific
membership requirements for a
duly cons tuted IRB. There are
three types of members required
to reach quorum, and while all IRB
members are able to comment on
all aspects of proposed research –
each type of member does bring a
specific perspec ve to the review
process.

Non‐Scien st
Members whose primary concerns are in non‐
scien fic areas are able to provide perspec ves
on proposed research not oﬀered by scien fic
review alone. These IRB members contribute
things like comments on consent readability,
perspec ve on consent and recruitment
processes, and evalua ons of risks related to
the research that stem from issues like privacy,
confiden ality, social s gma, etc…



Unaﬃliated
Members who are unaﬃliated with the
ins tu on are the voice of the community. They
are also able to comment on proposed research
without the pressure of ins tu onal concerns.
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The Non‐Scientist Reviewer
Bringing Your Perspec ve to the IRB

Collabora on is the key to a successful review board. Each commi ee member is a
valued part of the group and as such we hope you will establish and maintain a
rela onship of func onal trust with all members. All members regardless of job tle,
level of educa onal prepara on, or any other diﬀerences are essen al to the review
process.
As a nonscien st, your role is primarily that of an advocate for the research par cipants;
you serve as the voice of the subject, par cularly regarding issues related to informed
consent, par cipant vulnerabili es, and risks or benefits posed by the research. Consent
is based on what a reasonable person would want to be told; you are able to speak from
this point of view as the informed outsider, bridging the informa on gap between
researchers and subjects. Essen ally, during the review process you are able to present
concerns in a diﬀerent way than scien sts, helping to ensure that par cipants are
adequately protected.

The Ins tu onal Review Board reviews several types of applica ons. Non‐
scien st members are typically assigned to review New and Con nuing
Review applica ons:


New Protocols: New studies are assigned to two full board members for
review and presenta on.



Con nuing Reviews: Required annual reports of approved research are
assigned to two full board members for review and presenta on.



Modifica ons: Most changes to approved research requires review and
approval by the IRB. These are typically assigned to one full board member.



Reportable Events: Problems o en arise during research that require review
by the IRB. These are assigned to a review with exper se in the field of
research.



Expedited and Exempt Protocols: Are assigned to HRPO staﬀ reviewers (who
may refer items to the full board for review).
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Vulnerable Populations


The regula ons (45 CFR 46 Subpart
B, C, D) provide specific guidance for
research par cipants that are
considered vulnerable. While the
three described here are men oned
specifically in the regula ons,
cogni vely impaired, economically
disadvantaged, educa onally
disadvantaged, student,
transna onal par cipants are
examples of other popula ons
considered vulnerable in the
context of research. The Non‐
Scien st member plays a role in
iden fying these par cipants.

Pregnant Women, Human Fetuses and
Neonates

Research involving pregnant women and fetuses may
only be approvable if it meets a lengthy list of
condi ons described in the regula ons. For research
that holds out the prospect of direct benefit solely to
the fetus, the consent of the pregnant woman and
the father is required. For research that holds out the
prospect of direct benefit to the pregnant woman,
both to the woman and the fetus, or when a minimal
risks study oﬀers no benefit to the woman and fetus
and the proposed research is the only way to collect
important biomedical knowledge – the consent of the
pregnant woman is necessary.


Prisoners

Prisoners are considered vulnerable due to being in
an environment that can inhibit free choice. Research
involving prisoners may only be allowed in four
categories described in the regula ons. An IRB
prisoner representa ve is required for the review of
these studies.


Children (Minors)

The regula ons define children as par cipants that
have not reached the legal age to consent to
treatments or procedures involved in the research.
There are four categories of research for children,
generally dis nguished by the risks and benefits of
proposed research. Each category has specific assent
and consent requirements that need to be discussed
during the IRB mee ng. An appropriate consent and
assent process should be described in the IRB
applica on. When evalua ng the assent process for a
study that involves children, the age, physical
condi on, psychological state, and maturity of the
proposed study popula on should also be considered.
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Three Types of IRB Review
Nuts and Bolts of Reviewing Studies
New Protocols:
Review the myIRB applica on and all material for approval (located in myIRB under
“a achments”):








Study Protocol.
Grant Applica on (if applicable).
Inves ga onal Brochure (if applicable).
Informed Consent Document.
Recruitment Materials.
Data Collec on instruments.
Answer the ques on: Does the protocol, as presented, meet all the criteria
for approval?

Con nuing Reviews:
Begin with the assump on that the previous review was adequate/appropriate. The
focus here should be on the ongoing progress of the study:


Have there been any changes or new informa on which aﬀects the
approvability of the study? If so, should changes be made to the consent
form or study documents?
 Is there anything which might alter the willingness of subjects to
con nue/enroll?
 Are recruitment goals being met?
 Answer the ques on: Given the progress/events that have occurred since
the last review, does the study s ll meet all the criteria for approval?

Modifica ons :
Review the proposed changes to previously approved research in the myIRB
applica on, which:



May involve significant change in aims or study design.
May have the poten al to adversely aﬀect the previous risk/benefit
analysis.
 May require revisions to the Informed Consent document and/or the
reconsent of par cipants.
 Answer the ques on: Given the proposed changes, does the study s ll
meet all the criteria for approval?
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Before The Meeting

Here are some things to keep in
mind when sharing your review with
the IRB during a mee ng.

 Review the myIRB applica on, study documents, and Informed Consent documents.
 If you have ques ons, look for answers before the mee ng by:
 Contact the PI directly
 Contact HRPO staﬀ/analysts and they can route your ques on to the PI
 Contact your mee ng chair or the other IRB member assigned to review the study

 If you have recommended revisions to the consent form that involve the addi on of specific
language, note your proposed addi ons for HRPO staﬀ/analysts.
 When you come to the mee ng, you should be prepared to recommend the study for approval or
provide specific con ngencies to approval.
 Be sure to fill out the reviewer sheet in myIRB and include any comments you wish to address in the
spaces provided.
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During The Meeting

Here are some things to keep in
mind when sharing your review with
the IRB during a mee ng.

 Limit the ini al summary of the purpose and procedures of the study (“what will happen to
par cipants”) to a few minutes. Provide a succinct, simple statement of the proposed research with
enough background to jus fy the performance of the research. Defer to other reviewers if you
would prefer.
 Provide any addi onal informa on that the en re commi ee needs to supplement the limited
materials they were provided for ini al review.
 If you have revisions to the Informed Consent document, the comments or proposed revisions
should be provided. Do not engage in “wordsmithing.” Proposed changes should be meaningful and
defined by the criteria for approvability.
 The concerns in your cri que should be framed around the criteria for approval. For example, if you
have a concern about the par cipant recruitment, state “I have a concern with regard to equitable
subject selec on,” and then state your concern.
 Address any relevant regulatory issues related to pregnant women and fetuses, children, prisoners,
or other vulnerable par cipants.
 End presenta on with a mo on and vote, indica ng risk level and length of approval:
 Approve as is
 Approve with con ngencies ‐ the study is only approvable

if the following changes are made...
 Tabled ‐ there is insuﬃcient informa on to evaluated the

approvability of the study, or the study is not approvable
without significant revisions.
 Disapprove ‐ the study is not approvable.
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On Being an IRB Member

The Challenge

As previously stated, it is impera ve to include
both scien st and nonscien st voices on
protocol reviews. However, some new
members have expressed feelings of
in mida on when star ng out as a reviewer,
being on a commi ee with researchers or
doctors who may have a be er understanding
of the scien fic terms and milieu. Self
confidence is essen al to being a successful
reviewer: please realize how important your
viewpoint is and feel free to express concerns
during a mee ng Many members claim it takes
up to 12 mee ngs (one year) to become truly
comfortable in their role as a reviewer.
‐
“Primary benefits include an opportunity to give
back to the St Louis area communi es which
have provided many blessings to me these past
19 years as well as the opportunity to learn
from fellow members and staﬀ.”

The Reward

A ending mee ngs and reviewing protocols can
be an excellent source of self educa on; you
will become familiar with terms, processes, and
ongoing medical protocols, all the while building
rela onships with other IRB members. Finally,
by volunteering as an IRB member, you are
serving your community and contribu ng to
ground‐breaking medical research, which can
be used worldwide to address health concerns.
‐
“Non‐scien fic community members are equally
qualified (and some mes more qualified) to
determine whether the risks are reasonable in
rela on to the benefits and whether the consent
form is complete and understandable. Maybe
we find it easier to put ourselves in the posi on
of the pa ent or the parent of the pediatric
pa ent. It’s a valuable perspec ve to bring to
the table and makes you feel like you are
making a small but real contribu on to these
important ac vi es.”

Bruce Lane, J.D.
Karen Davis, J.D.
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Resources:
Human Research Protec on Oﬃce (HRPO) Staﬀ and Website
314‐633‐7400 or h p://hrpohome.wustl.edu/


SWAT! and On Call staﬀ



myIRB online system



Scheduling issues



Protocol review ques ons

Linda Van Zandt, New Member Liaison
314‐633‐7452 or zandtl@wusm.wustl.edu


Assists in orienta on



Available for myIRB training



Accessible during first review process

Nikki Koehnemann, Administra ve Coordinator/Assistant to Dr. Green
314‐633‐7478 or koehnemannn@wusm.wustl.edu


General membership



Buddy system



Any other ques ons



New Member Training ques ons

Addi onal Reading:
Allen Hornblum. Acres of Skin: Human Experiments at Holmesburg Prison. (New York: Routledge,
1999)
James H. Jones. Bad Blood: The Tuskegee Syphilis Experiment. (New York: The Free Press, 1992)
Jordan Goodman and Anthony McElligo , eds. Useful Bodies: Humans in the Service of Medical
Science in the Twen eth Century. (Bal more: The Johns Hopkins University Press, 2008)
Rebecca Skloot. The Immortal Life of Henrie a Lacks. (New York: Broadway, 2011)
Laura Stark. Behind Closed Doors. (Chicago: University of Chicago Press, 2012)
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